サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1514901

狂犬病ワクチン市場：製品タイプ別、用途別、予防タイプ別、エンドユーザー別、国別、地域別-産業分析、市場規模、市場シェア、2024～2032年予測

Rabies Vaccine Market, By Product Type, By Application, By Prophylaxis Type, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日
ページ情報
英文 367 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
狂犬病ワクチン市場：製品タイプ別、用途別、予防タイプ別、エンドユーザー別、国別、地域別-産業分析、市場規模、市場シェア、2024～2032年予測
出版日: 2024年06月11日
発行: AnalystView Market Insights
ページ情報: 英文 367 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

レポートハイライト

狂犬病ワクチン市場規模は2023年に13億4,543万米ドルとなり、2024～2032年にかけてCAGR 4.5％で拡大

狂犬病ワクチン市場-市場力学

ペット飼育の増加とそれに伴う獣医療の増加により、ペット予防接種の必要性が高まっています。

ペット飼育の増加傾向に加え、獣医療に対する意識が高まっていることから、ペット予防接種の重要性が浮き彫りになっています。ペットを家族に迎える家庭が増えるにつれ、予防可能な病気からペットを守ることが最優先事項となっています。ワクチンは、狂犬病、ジステンパー、パルボウイルス、猫白血病など、重篤で死に至る可能性のあるさまざまな病気からペットを守る。調査によると、インドには3,100万頭以上のペットの犬がいます。持ち家所有者は賃貸者よりもペットを飼う傾向が強い：住宅所有者の58％が犬を、36％が猫を飼っているのに対し、賃貸住宅所有者はそれぞれ39％、29％です。インドでは11％の人が少なくとも4匹のペットを飼っています。ペットの飼育が増え続ける中、予防接種の重視はペットとその同伴者の健康を守るために不可欠です。定期的な予防接種は、責任あるペットケアの重要な要素であり、ペットがより健康で長生きすることを保証すると同時に、公衆衛生を守ることにもなります。

狂犬病ワクチン市場-主要洞察

弊社のリサーチアナリストの分析によると、世界市場は予測期間（2024～2032年）に約4.5%のCAGRで毎年成長すると予測されています。

予防法別では、曝露前予防が2023年に最大の市場シェアを示すと予測されます。

エンドユーザー別では、2023年に病院が主要なタイプでした。

用途別では、2023年には動物が主要タイプでした。

地域別では、北米が2023年の主要収益源であった

狂犬病ワクチン市場-セグメンテーション分析：

世界の狂犬病ワクチン市場は、製品タイプ、用途、予防法、エンドユーザー、地域に基づいてセグメント化されます。

市場は予防法に基づいて2つのカテゴリーに分けられます：曝露前予防と曝露後予防です。長期的な予防は曝露前予防薬によって提供され、狂犬病曝露の可能性がある場合に曝露後の迅速な治療の必要性を軽減します。曝露後予防の費用を考慮すると、この長期的な予防は長期的には費用対効果が高いと証明される可能性があります。

市場はエンドユーザーによって3つのカテゴリーに分けられます：病院、動物病院、その他です。世界のペット飼育率の増加により、狂犬病予防接種を含む獣医療サービスのニーズが高まっています。動物病院が犬や猫を含むペットに提供する予防医療には、定期的なワクチン接種プログラムが含まれます。免疫を維持するためには、定期的なワクチン接種が不可欠です。ブースター接種の頻度は、使用するワクチンや地域の法律によって異なるが、一般的には年1回から3年に1回です。

狂犬病ワクチン市場-地理的洞察

高い製品導入率、大手メーカーの存在、狂犬病ワクチン接種を促進する政府のキャンペーンにより、北米は狂犬病ワクチンの重要な市場となっています。主要貢献国は米国、カナダ、メキシコの3カ国で、米国はその洗練された医療システムと高い認知度によりリードしています。北米が市場シェアでリードしているのは、疾病予防戦略としてワクチンが広く使用されていることと、医療産業における研究開発の環境が整っているためです。Centres for Disease Prevention and Preventionの推定によると、狂犬病の発見と予防に関連するアメリカの年間医療費は3億米ドルを超えています。

狂犬病ワクチン市場-競合情勢：

Sanofi（フランス）、Merck &Co.Inc.、Pfizer（米国）、VBI Vaccines Inc.（米国）、CSC Pharmaceuticals International、Bio-Med Pvt. Ltd.（米国）、Bavarian Nordic（米国）、Solvay（米国）、Informa plc.（米国）などの大手企業が市場に参入しています。市場全体の成長をサポートするために、これらの業界参入企業は、生産能力の拡大、M&A、パートナーシップ、新製品開発、買収など、いくつかの方法を実施しています。さらに、分析期間中、主要な業界参入企業による研究開発への投資が拡大し、市場の拡大をサポートすると考えられます。例えば、2024年3月、狂犬病撲滅への継続的なコミットメントの一環として、Merck &Co.（ニュージャージー州ラーウェイ）の一部門であるMerck Animal Healthは、Worldwide Veterinary Service（WVS）のMission RabiesプログラムにNOBIVAC（R）狂犬病ワクチンを寄付しました。今後5年間にわたり、この寄付金はこの非営利団体が毎年必要とする狂犬病ワクチンを支援し続ける。

目次

第1章 狂犬病ワクチン市場概要

  • 調査範囲
  • 市場推定年

第2章 エグゼクティブ概要

  • 市場内訳
  • 競合考察

第3章 狂犬病ワクチンの主要市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 狂犬病ワクチン産業の調査

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長展望マッピング
  • 規制枠組み分析

第5章 狂犬病ワクチン市場： COVID-19の影響分析

  • COVID-19前の影響分析
  • COVID-19後の影響分析

第6章 狂犬病ワクチン市場情勢

  • 狂犬病ワクチン市場シェア分析、2023年
  • 主要メーカー別内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 狂犬病ワクチン市場-製品タイプ別

  • 概要
    • 製品タイプ別セグメントシェア分析
    • ベロ細胞狂犬病ワクチン
    • ベビーハムスター腎臓（BHK）
    • 鶏胚細胞狂犬病ワクチン
    • その他

第8章 狂犬病ワクチン市場-用途別

  • 概要
    • 用途別セグメントシェア分析
    • 人間
    • 動物

第9章 狂犬病ワクチン市場-予防法別

  • 概要
    • 予防法別セグメントシェア分析
    • 曝露前予防
    • 曝露後予防

第10章 狂犬病ワクチン市場-エンドユーザー別

  • 概要
    • エンドユーザー別セグメントシェア分析
    • 病院
    • 動物病院
    • その他

第11章 狂犬病ワクチン市場-地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋
    • 概要
    • アジア太平洋の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東・アフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第12章 主要ベンダー分析-狂犬病ワクチン業界

  • 競合ダッシュボード
  • 企業プロファイル
    • Serum Institute of India Pvt. Ltd
    • Novartis AG
    • Cadila Pharmaceuticals
    • Merck &Co., Inc.
    • Sanofi
    • ADS Diagnostic Ltd
    • GSK plc
    • Berna Biotech Pharma GmbH
    • AstraZeneca
    • その他

第13章 アナリストの全方位展望

図表

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Rabies Vaccine Market: Product Type Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Product Type
  • TABLE Global Rabies Vaccine Market, by Product Type 2019-2032 (USD Million)
  • TABLE Rabies Vaccine Market: Application Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Rabies Vaccine Market, by Application 2019-2032 (USD Million)
  • TABLE Rabies Vaccine Market: Prophylaxis Type Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Prophylaxis Type
  • TABLE Global Rabies Vaccine Market, by Prophylaxis Type 2019-2032 (USD Million)
  • TABLE Rabies Vaccine Market: End User Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by End User
  • TABLE Global Rabies Vaccine Market, by End User 2019-2032 (USD Million)
  • TABLE Rabies Vaccine Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Rabies Vaccine Market, by Region 2019-2032 (USD Million)
  • TABLE North America Rabies Vaccine Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Rabies Vaccine Market, by Product Type, 2019-2032 (USD Million)
  • TABLE North America Rabies Vaccine Market, by Application, 2019-2032 (USD Million)
  • TABLE North America Rabies Vaccine Market, by Prophylaxis Type, 2019-2032 (USD Million)
  • TABLE North America Rabies Vaccine Market, by End User, 2019-2032 (USD Million)
  • TABLE Europe Rabies Vaccine Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Rabies Vaccine Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Europe Rabies Vaccine Market, by Application, 2019-2032 (USD Million)
  • TABLE Europe Rabies Vaccine Market, by Prophylaxis Type, 2019-2032 (USD Million)
  • TABLE Europe Rabies Vaccine Market, by End User, 2019-2032 (USD Million)
  • TABLE Asia Pacific Rabies Vaccine Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Rabies Vaccine Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Asia Pacific Rabies Vaccine Market, by Application, 2019-2032 (USD Million)
  • TABLE Asia Pacific Rabies Vaccine Market, by Prophylaxis Type, 2019-2032 (USD Million)
  • TABLE Asia Pacific Rabies Vaccine Market, by End User, 2019-2032 (USD Million)
  • TABLE Latin America Rabies Vaccine Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Rabies Vaccine Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Latin America Rabies Vaccine Market, by Application, 2019-2032 (USD Million)
  • TABLE Latin America Rabies Vaccine Market, by Prophylaxis Type, 2019-2032 (USD Million)
  • TABLE Latin America Rabies Vaccine Market, by End User, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Rabies Vaccine Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Rabies Vaccine Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Rabies Vaccine Market, by Application, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Rabies Vaccine Market, by Prophylaxis Type, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Rabies Vaccine Market, by End User, 2019-2032 (USD Million)

List of Figures

  • FIGURE Rabies Vaccine Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2023
  • FIGURE Product Type segment market share analysis, 2023 & 2032
  • FIGURE Product Type segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Application segment market share analysis, 2023 & 2032
  • FIGURE Application segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Prophylaxis Type segment market share analysis, 2023 & 2032
  • FIGURE Prophylaxis Type segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE End User segment market share analysis, 2023 & 2032
  • FIGURE End User segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Regional segment market share analysis, 2023 & 2032
  • FIGURE Regional segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE North America Rabies Vaccine Market share and leading players, 2023
  • FIGURE Europe Rabies Vaccine Market share and leading players, 2023
  • FIGURE Asia Pacific Rabies Vaccine Market share and leading players, 2023
  • FIGURE Latin America Rabies Vaccine Market share and leading players, 2023
  • FIGURE Middle East and Africa Rabies Vaccine Market share and leading players, 2023
  • FIGURE North America market share analysis by country, 2023
  • FIGURE U.S. Rabies Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Canada Rabies Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Europe Rabies Vaccine Market share analysis by country, 2023
  • FIGURE Germany Rabies Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Spain Rabies Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Italy Rabies Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE France Rabies Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE UK Rabies Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Russia Rabies Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Netherlands Rabies Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Sweden Rabies Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Poland Rabies Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of the Europe Rabies Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Asia Pacific Rabies Vaccine Market share analysis by country, 2023
  • FIGURE India Rabies Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE China Rabies Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Japan Rabies Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE South Korea Rabies Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Australia Rabies Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Thailand Rabies Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Indonesia Rabies Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Philippines Rabies Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of APAC Rabies Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America Rabies Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America Rabies Vaccine Market share analysis by country, 2023
  • FIGURE Brazil Rabies Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Mexico Rabies Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Argentina Rabies Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Colombia Rabies Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of LATAM Rabies Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa Rabies Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa Rabies Vaccine Market share analysis by country, 2023
  • FIGURE Saudi Arabia Rabies Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE United Arab Emirates Rabies Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Israel Rabies Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Turkey Rabies Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Algeria Rabies Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Egypt Rabies Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of MEA Rabies Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
目次
Product Code: ANV3021

REPORT HIGHLIGHT

Rabies Vaccine Market size was valued at USD 1,345.43 million in 2023, expanding at a CAGR of 4.5% from 2024 to 2032.

Growing pet ownership and the corresponding rise in veterinary care emphasize the need for pet vaccinations, thereby expanding the market. Ongoing research and development leading to improved vaccines with better efficacy, longer protection, and fewer side effects stimulate market demand. Increased awareness about rabies prevention and the importance of vaccination through educational campaigns positively impacts market growth. However, there are concerns over potential side effects and adverse reactions that can deter individuals from getting vaccinated.

Rabies Vaccine Market- Market Dynamics

Growing pet ownership and the corresponding rise in veterinary care emphasize the need for pet vaccinations

The growing trend in pet ownership, coupled with an increasing awareness of veterinary care, underscores the importance of pet vaccinations. As more households welcome pets into their families, ensuring these animals are protected against preventable diseases becomes a top priority. Vaccines protect pets from a variety of serious and potentially fatal diseases, such as rabies, distemper, parvovirus, and feline leukemia. According to the survey, there are over 31 million pet dogs in India. Homeowners are more likely to own pets than renters: 58% of homeowners have a dog and 36% have a cat versus 39% and 29% of renters respectively. 11% of people in India own at least four pets. As pet ownership continues to rise, the emphasis on vaccinations is essential for safeguarding the health of pets and their human companions. Regular vaccinations are a vital component of responsible pet care, ensuring that pets live longer, healthier lives while also protecting public health.

Rabies Vaccine Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 4.5% over the forecast period (2024-2032)

Based on Prophylaxis Type segmentation, Pre-Exposure Prophylaxis was predicted to show maximum market share in the year 2023

Based on application segmentation, Hospitals were the leading type in 2023

Based on application segmentation, the animal was the leading type in 2023

Based on region, North America was the leading revenue generator in 2023

Rabies Vaccine Market- Segmentation Analysis:

The Global Rabies Vaccine Market is segmented based on Product Type, Application, Prophylaxis Type, End User, and Region.

The market is divided into two categories based on prophylaxis type: Pre-Exposure Prophylaxis, and Post-Exposure Prophylaxis. Long-term protection is provided by pre-exposure prophylaxis, which lessens the requirement for prompt post-exposure care in the event of a possible rabies exposure. When post-exposure prophylaxis costs are taken into account, this long-term protection may prove to be cost-effective in the long run.

The market is divided into three categories based on end-users: Hospitals, Veterinary clinics, and Others. The increased global pet ownership rate has led to a larger need for veterinary services, including rabies vaccinations. The preventative care that veterinary clinics offer to pets, including dogs and cats, includes routine vaccination programs. Regular booster vaccinations are essential for maintaining immunity. The frequency of boosters depends on the vaccine used and local laws, but it generally ranges from annually to every three years.

Rabies Vaccine Market- Geographical Insights

Due to a high rate of product introductions, the existence of major manufacturers, and government campaigns to promote rabies vaccination, North America is a substantial market for rabies vaccines. Three major contributors are the United States, Canada, and Mexico with the United States leading because of its sophisticated healthcare system and high degree of awareness. North America leads the area in terms of market share due to the widespread use of vaccines as a disease prevention strategy and a conducive environment for research and development in the healthcare industry. According to estimates from the Centres for Disease Prevention and Prevention, the annual health costs in America related to the detection and prevention of rabies have surpassed USD 300 million.

Rabies Vaccine Market- Competitive Landscape:

Sanofi (France), Merck & Co. Inc., Pfizer (USA), VBI Vaccines Inc. (USA), CSC Pharmaceuticals International, Bio-Med Pvt. Ltd., Bavarian Nordic (USA), Solvay (USA), Informa plc. (USA), and other major players are among those involved in the market. To support the market's overall growth, these industry players are implementing several methods, including capacity expansion, mergers and acquisitions, partnerships, new product development, and acquisitions. Additionally, during the analysis period, growing investments made in research & development by the major industry players would support market expansion. For instance, In March 2024, As part of its ongoing commitment to eradicating rabies, Merck Animal Health, a division of Merck & Co., Inc., Rahway, N.J., donated NOBIVAC(R) rabies vaccines to the Worldwide Veterinary Service (WVS) Mission Rabies program. Over the next five years, the donations will continue to support this non-profit organization's annual rabies vaccine requirements.

Recent Developments:

In February 2024, US-based biotech Replicate Bioscience announced positive preliminary data where its self-replicating RNA (srRNA) rabies vaccine, RBI-4000 achieved a strong immune response against the rabies virus.

In March 2022, The University of Oxford and the Ifakara Health Institute announced the vaccination of the first participants in a Phase Ib/II trial testing a novel rabies vaccine in human volunteers in Tanzania.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL RABIES VACCINE MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Serum Institute of India Pvt. Ltd

Novartis AG

Cadila Pharmaceuticals

Merck & Co., Inc.

Sanofi

ADS Diagnostic Ltd

GSK plc

Berna Biotech Pharma GmbH

AstraZeneca

Others

GLOBAL RABIES VACCINE MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Vero Cell Rabies Vaccine
  • Baby Hamster Kidney (BHK)
  • Chick Embryo Cell Rabies Vaccine
  • Others

GLOBAL RABIES VACCINE MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Human
  • Animal

GLOBAL RABIES VACCINE MARKET, BY PROPHYLAXIS TYPE - MARKET ANALYSIS, 2019 - 2032

  • Pre-Exposure Prophylaxis
  • Post-Exposure Prophylaxis

GLOBAL RABIES VACCINE MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals
  • Veterinary clinics
  • Others

GLOBAL RABIES VACCINE MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Rabies Vaccine Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Rabies Vaccine Market Snippet by Product Type
    • 2.1.2. Rabies Vaccine Market Snippet by Application
    • 2.1.3. Rabies Vaccine Market Snippet by Prophylaxis Type
    • 2.1.4. Rabies Vaccine Market Snippet by End User
    • 2.1.5. Rabies Vaccine Market Snippet by Country
    • 2.1.6. Rabies Vaccine Market Snippet by Region
  • 2.2. Competitive Insights

3. Rabies Vaccine Key Market Trends

  • 3.1. Rabies Vaccine Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Rabies Vaccine Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Rabies Vaccine Market Opportunities
  • 3.4. Rabies Vaccine Market Future Trends

4. Rabies Vaccine Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Rabies Vaccine Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Rabies Vaccine Market Landscape

  • 6.1. Rabies Vaccine Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Rabies Vaccine Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2023 & 2032 (%)
    • 7.1.2. Vero Cell Rabies Vaccine
    • 7.1.3. Baby Hamster Kidney (BHK)
    • 7.1.4. Chick Embryo Cell Rabies Vaccine
    • 7.1.5. Others

8. Rabies Vaccine Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 8.1.2. Human
    • 8.1.3. Animal

9. Rabies Vaccine Market - By Prophylaxis Type

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Prophylaxis Type, 2023 & 2032 (%)
    • 9.1.2. Pre-Exposure Prophylaxis
    • 9.1.3. Post-Exposure Prophylaxis

10. Rabies Vaccine Market - By End User

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 10.1.2. Hospitals
    • 10.1.3. Veterinary clinics
    • 10.1.4. Others

11. Rabies Vaccine Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Rabies Vaccine Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Prophylaxis Type, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Prophylaxis Type, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Prophylaxis Type, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Rabies Vaccine Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Prophylaxis Type, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Prophylaxis Type, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.9. Italy
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.9.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.9.5. Italy Market Size and Forecast, By Prophylaxis Type, 2019 - 2032 (US$ Million)
      • 11.3.9.6. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.10. United Kingdom
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. United Kingdom Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.10.4. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.10.5. United Kingdom Market Size and Forecast, By Prophylaxis Type, 2019 - 2032 (US$ Million)
      • 11.3.10.6. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.11. France
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.11.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.11.5. France Market Size and Forecast, By Prophylaxis Type, 2019 - 2032 (US$ Million)
      • 11.3.11.6. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.12. Russia
      • 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.2. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.12.3. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Russia Market Size and Forecast, By Prophylaxis Type, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.13. Netherlands
      • 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.2. Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.13.3. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.13.4. Netherlands Market Size and Forecast, By Prophylaxis Type, 2019 - 2032 (US$ Million)
      • 11.3.13.5. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.2. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Prophylaxis Type, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.15. Poland
      • 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.2. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.15.3. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Poland Market Size and Forecast, By Prophylaxis Type, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.16. Rest of Europe
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Rest of the Europe Market Size and Forecast, By Prophylaxis Type, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Rabies Vaccine Key Manufacturers in Asia Pacific
    • 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. Asia Pacific Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.4.5. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.6. Asia Pacific Market Size and Forecast, By Prophylaxis Type, 2019 - 2032 (US$ Million)
    • 11.4.7. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.8. India
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.8.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.8.5. India Market Size and Forecast, By Prophylaxis Type, 2019 - 2032 (US$ Million)
      • 11.4.8.6. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.9. China
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.9.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.9.5. China Market Size and Forecast, By Prophylaxis Type, 2019 - 2032 (US$ Million)
      • 11.4.9.6. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Prophylaxis Type, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Prophylaxis Type, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Prophylaxis Type, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.13. Thailand
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Thailand Market Size and Forecast, By Prophylaxis Type, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.14. Indonesia
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Indonesia Market Size and Forecast, By Prophylaxis Type, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Prophylaxis Type, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Prophylaxis Type, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.5. Latin America
    • 11.5.1. Overview
    • 11.5.2. Rabies Vaccine Key Manufacturers in Latin America
    • 11.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. Latin America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.5.5. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.6. Latin America Market Size and Forecast, By Prophylaxis Type, 2019 - 2032 (US$ Million)
    • 11.5.7. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Prophylaxis Type, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Prophylaxis Type, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Prophylaxis Type, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Prophylaxis Type, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Prophylaxis Type, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa
    • 11.6.1. Overview
    • 11.6.2. Rabies Vaccine Key Manufacturers in Middle East and Africa
    • 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.6.5. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.6. Middle East and Africa Market Size and Forecast, By Prophylaxis Type, 2019 - 2032 (US$ Million)
    • 11.6.7. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Prophylaxis Type, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Prophylaxis Type, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Prophylaxis Type, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Prophylaxis Type, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Prophylaxis Type, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Prophylaxis Type, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Prophylaxis Type, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Rabies Vaccine Industry

  • 12.1. Competitive Dashboard
  • 12.2. Company Profiles
    • 12.2.1. Serum Institute of India Pvt. Ltd
    • 12.2.2. Novartis AG
    • 12.2.3. Cadila Pharmaceuticals
    • 12.2.4. Merck & Co., Inc.
    • 12.2.5. Sanofi
    • 12.2.6. ADS Diagnostic Ltd
    • 12.2.7. GSK plc
    • 12.2.8. Berna Biotech Pharma GmbH
    • 12.2.9. AstraZeneca
    • 12.2.10. Others

13. 360 Degree Analyst View

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us